Toxicology of Trastuzumab: An Insight into Mechanisms of Cardiotoxicity.
This article discusses various mechanisms that have been proposed for the cardiotoxic effects of trastuzumab and the potential risk factors that can lead to cardiotoxicity. The recently approved anti-HER2 monoclonal antibodies including pertuzumab and ado-trastuzumab (T-DM1) are also discussed.
PMID: 29189161 [PubMed - as supplied by publisher]
Source: Current Cancer Drug Targets - Category: Cancer & Oncology Authors: An J, Sheikh MS Tags: Curr Cancer Drug Targets Source Type: research
More News: Cancer | Cancer & Oncology | Cardiology | Gastric (Stomach) Cancer | Gastroenterology | Heart | HER2 | Herceptin | Study | Toxicology